Use of DOACs in patients with ICH and AF resulted in a remarkable reduction in ischemic stroke, but that benefit was partially offset by an increase in ICH recurrence.

Early findings suggest that IA tenecteplase after successful thrombectomy is safe and improves functional outcomes over standard care in anterior circulation LVO stroke.

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

An instructional video regarding two stroke-related mnemonics was linked to faster 911 call response for suspected stroke, ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

More than 100 million people globally have had a stroke, but there are ways to reduce your risk and spot the signs of stroke ...

Stroke survivors were more likely to have little or no disability after 90 days if a clot was removed from a large brain artery followed by the injection of the clot-dissolving medication tenecteplase ...

A protocol designed to progressively increase physical therapy intensity for stroke survivors improved walking distance, ...

Boehringer Ingelheim India has signed an MoU with EMRI Green Health Services to improve pre-hospital stroke care in India. Through specialized training and resources, the initiative aims to enhance ...

Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of ...